HLA genotype as a marker of multiple sclerosis prognosis: A pilot study. 2017

Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
Department of Neurology, Hôpital Erasme, Université Libre de Bruxelles, Belgium. Electronic address: andreas.Lysandropoulos@erasme.ulb.ac.be.

OBJECTIVE The identification of a biomarker with prognostic value is an unmet need in multiple sclerosis (MS). The objective of this study was to investigate a possible association of HLA genotype with disease status and progression in MS, based on comprehensive and sensitive clinical and magnetic resonance imaging (MRI) parameters to measure disease effects. METHODS A total of 118 MS patients (79 females, 39 males) underwent HLA typing. Patient MS status was assessed at two time points in a 2-year interval, based on clinical scores (including EDSS, MSSS, T25FW, 9-HPT, SDMT, BVMT, CVLT-II) and MRI evaluations. Quantitative brain MRI values were obtained for whole brain atrophy, FLAIR lesion volume change and number of new lesions using MSmetrix. Predefined HLA patient groups were compared as of disease status and progression. Global assessment was achieved by an overall t-statistic and assessment per measurement by a Welch test and/or Mann Whitney U test. The effects of multiple covariates, including age, gender and disease duration as well as scan parameters, were also evaluated using a regression analysis. RESULTS The HLA-A*02 allele was associated with better outcomes in terms of MSSS, EDSS and new lesion count (Welch test p-value<0.05). The HLA-B*07 and HLA-B*44 alleles showed a global negative effect on disease status, although none of the measurements reached significance (p-value<0.05). Results for the HLA-DRB1*15, HLA-DQB1*06 and HLA-B*08 alleles were inconclusive. The influence of the confounding variables on the statistical analysis was limited.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D004185 Disability Evaluation Determination of the degree of a physical, mental, or emotional handicap. The diagnosis is applied to legal qualification for benefits and income under disability insurance and to eligibility for Social Security and workmen's compensation benefits. Disability Evaluations,Evaluation, Disability,Evaluations, Disability
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes

Related Publications

Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
March 2020, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
April 2013, Journal of neuroimmunology,
Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
November 2020, Multiple sclerosis and related disorders,
Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
May 1994, Journal of neurology,
Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
December 2001, Archives of neurology,
Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
January 1981, Journal of neurology,
Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
July 2007, Journal of neuroinflammation,
Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
September 2022, Journal of clinical medicine,
Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
September 2016, Arquivos de neuro-psiquiatria,
Andreas P Lysandropoulos, and Nicolas Mavroudakis, and Massimo Pandolfo, and Kaoutar El Hafsi, and Wim van Hecke, and Anke Maertens, and Thibo Billiet, and Annemie Ribbens
January 2000, General hospital psychiatry,
Copied contents to your clipboard!